explore -WSS

explore

author：knowledge 2025-10-01 23:03:15 - browse：8817

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Study: New antibiotic targets gonorrhea as well as last existing drug

entertainment

WSS

Victims of gun violence feel impacts long after bullet wound

More doctors should go into startup world

Prior authorization reform is both possible and imperative

UCSF medical school apologizes for unethical prisoner experiments

What causes osteoarthritis? Researchers study link to brain protein

High breast density mammograms need follow

leisure time

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Printout prescription drug information shouldn’t go digital

United colonoscopy coverage change 'may cost lives,' doctors say

Extreme heat events are a public health emergency

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Head of FDA's diagnostics center, who led through Covid, retires

Medical leaders decry Supreme Court decision on affirmative action

The inclusion problem at the heart of rehabilitation research

Heart attack and stroke risk calculators need revising

Extreme heat events are a public health emergency

knowledge

Printout prescription drug information shouldn’t go digital

Medicare bonuses could stop drug shortages under Senate plan

Just how powerful is the placebo effect?

TikTok, Instagram influencers need more rules for drug ads

Study: New antibiotic targets gonorrhea as well as last existing drug

The new shift in health care is toward less care

entertainment

entertainment

entertainment

hotspot